Fortis Advisors, LLC Biogen Inc. Transaction History

Fortis Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$242.95 - $284.63 $69,240 - $81,119	-285 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$264.77 - $305.71 $4,501 - $5,197	-17 Reduced 5.63%	285 $81,000
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $201,496 - $266,846	-779 Reduced 72.06%	302 $81,000
Q1 2020 May 14, 2020	SELL	$268.85 - $341.04 $11,829 - $15,005	-44 Reduced 3.91%	1,081 $342,000
Q3 2019 Nov 14, 2019	BUY	$217.44 - $243.88 $244,620 - $274,365	1,125 New	1,125 $262,000
Q4 2018 Feb 13, 2019	SELL	$278.5 - $352.75 $21,723 - $27,514	-78 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $20,086 - $23,938	78 New	78 $23,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Fortis Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Fortis Advisors, LLC with notifications on news.